A Deep Dive Into Cannabinoid Pharmacology
Sitting Down With… Roger Pertwee, Emeritus Professor, University of Aberdeen, UK.
What was your entry point into cannabis research?
I studied biochemistry at Oxford University in the 1960s. During my studies, I had the opportunity to work with the British Army Royal Engineers, which included an army diving course. As part of the safety training, I learned about “rapture of the deep” (also known as inert gas narcosis), a phenomenon in which breathable gases like nitrogen cause feelings of drunkenness when descending below 30 m. I was fascinated by the idea that the very air we breathe could have such a potent effect and sought out a PhD on the subject with a prominent pharmacology professor at Oxford, William Paton.
After my PhD, Professor Paton offered me a postdoc position exploring the pharmacological actions of some of the main cannabinoids and developing standard tests to measure their effects. We extracted our cannabinoids from bottles of a dark green liquid called “tincture of cannabis,” still legally sold as a medicine in Britain at that time.
A few years later and newly married, I decided I needed a permanent job and in 1974 I took a lectureship at the University of Aberdeen in Scotland, where I have continued studying cannabinoids ever since.
You are co-discoverer of the first-known endocannabinoid, anandamide – how did that come about?
Read the full article now
Log in or register to read this article in full and gain access to The Cannabis Scientist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Cannabis Scientist magazine